Dow Up 0.23% Nasdaq Up 0.16%

Navidea Biopharmaceuticals, Inc (NAVB)

-NYSE MKT
1.25 Down 0.01(0.79%) 9:53AM EST - Nasdaq Real Time Price
Prev Close:1.26
Open:1.26
Bid:1.25 x 7300
Ask:1.26 x 8500
1y Target Est:4.31
Beta:1.61
Next Earnings Date:N/A
Day's Range:1.25 - 1.26
52wk Range:0.97 - 2.25
Volume:26,927
Avg Vol (3m):861,948
Market Cap:187.71M
P/E (ttm):N/A
EPS (ttm):-0.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NAVB

Comparison

Symbol% ChgMkt Cap
NAVBDown 0.79%187.71M
LLYUp 1.38%73.00B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):41.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.24
Quarterly EPS Est (Dec-14) :-0.05
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback